Subclinical leaflet thrombosis after transcatheter aortic valve implantation: no association with left ventricular reverse remodeling at 1-year follow-up.
Aged
Aged, 80 and over
Aortic Valve
/ diagnostic imaging
Aortic Valve Stenosis
/ complications
Case-Control Studies
Female
Follow-Up Studies
Humans
Male
Predictive Value of Tests
Thrombosis
/ complications
Transcatheter Aortic Valve Replacement
/ adverse effects
Treatment Outcome
Ventricular Function, Left
Ventricular Remodeling
Aortic stenosis
Hypo-attenuated leaflet thickening
Left ventricular reverse remodeling
Multi-detector row computed tomography
Subclinical leaflet thrombosis
Transcatheter aortic valve implantation
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
27
07
2021
accepted:
05
10
2021
pubmed:
17
10
2021
medline:
19
3
2022
entrez:
16
10
2021
Statut:
ppublish
Résumé
Hypo-attenuated leaflet thickening (HALT) of transcatheter aortic valves is detected on multidetector computed tomography (MDCT) and reflects leaflet thrombosis. Whether HALT affects left ventricular (LV) reverse remodeling, a favorable effect of LV afterload reduction after transcatheter aortic valve implantation (TAVI) is unknown. The aim of this study was to examine the association of HALT after TAVI with LV reverse remodeling. In this multicenter case-control study, patients with HALT on MDCT were identified, and patients without HALT were propensity matched for valve type and size, LV ejection fraction (LVEF), sex, age and time of scan. LV dimensions and function were assessed by transthoracic echocardiography before and 12 months after TAVI. Clinical outcomes (stroke or transient ischemic attack, heart failure hospitalization, new-onset atrial fibrillation, all-cause mortality) were recorded. 106 patients (age 81 ± 7 years, 55% male) with MDCT performed 37 days [IQR 32-52] after TAVI were analyzed (53 patients with HALT and 53 matched controls). Before TAVI, all echocardiographic parameters were similar between the groups. At 12 months follow-up, patients with and without HALT showed a significant reduction in LV end-diastolic volume, LV end-systolic volume and LV mass index (from 125 ± 37 to 105 ± 46 g/m
Identifiants
pubmed: 34655348
doi: 10.1007/s10554-021-02438-2
pii: 10.1007/s10554-021-02438-2
pmc: PMC8926967
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
695-705Informations de copyright
© 2021. The Author(s).
Références
Eur Heart J. 2017 Jul 21;38(28):2201-2207
pubmed: 28838044
Lancet. 2017 Jun 17;389(10087):2383-2392
pubmed: 28330690
Eur Heart J Cardiovasc Imaging. 2020 Oct 1;21(10):1144-1151
pubmed: 31665257
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1164-1171
pubmed: 29929639
Eur Heart J. 2016 Jul 21;37(28):2263-71
pubmed: 26446193
N Engl J Med. 2020 Jan 9;382(2):111-119
pubmed: 31733181
J Thorac Cardiovasc Surg. 2011 Aug;142(2):285-91
pubmed: 21272899
JACC Cardiovasc Interv. 2017 Apr 10;10(7):686-697
pubmed: 28385406
Eur Heart J Cardiovasc Imaging. 2021 Jan 1;22(1):82-91
pubmed: 31942609
Eur Heart J Cardiovasc Imaging. 2016 Jun;17(6):589-90
pubmed: 27143783
Circ Cardiovasc Imaging. 2019 Dec;12(12):e009608
pubmed: 31826675
JACC Cardiovasc Imaging. 2019 Jan;12(1):135-145
pubmed: 30448122
JACC Cardiovasc Imaging. 2019 Jan;12(1):1-24
pubmed: 30621986
J Am Coll Cardiol. 2016 Nov 8;68(19):2059-2069
pubmed: 27580689
Am Heart J. 2014 Aug;168(2):150-9.e1-7
pubmed: 25066553
J Am Coll Cardiol. 2020 Jun 23;75(24):3003-3015
pubmed: 32553252
Eur Heart J Qual Care Clin Outcomes. 2021 Jan 25;7(1):107-108
pubmed: 32479593
J Am Coll Cardiol. 2017 Mar 14;69(10):1313-1346
pubmed: 28063810
Eur Heart J. 2020 Sep 1;41(33):3184-3197
pubmed: 32930773
N Engl J Med. 2014 Aug 21;371(8):744-56
pubmed: 25140960
Eur Heart J. 2017 Apr 21;38(16):1207-1217
pubmed: 28369242
N Engl J Med. 2015 Nov 19;373(21):2015-24
pubmed: 26436963
Circ Cardiovasc Interv. 2019 Feb;12(2):e007349
pubmed: 30732472
Eur Heart J Cardiovasc Imaging. 2019 Oct 1;20(10):1105-1111
pubmed: 30932153
Circ J. 2018 Jun 25;82(7):1735-1742
pubmed: 29618696
Br J Radiol. 2018 Oct;91(1090):20180196
pubmed: 30004788
JACC Cardiovasc Interv. 2014 Jun;7(6):662-73
pubmed: 24947722
Am J Cardiol. 2017 Oct 1;120(7):1198-1202
pubmed: 28823482
J Clin Invest. 1975 Jul;56(1):56-64
pubmed: 124746
Circ Cardiovasc Interv. 2015 Apr;8(4):
pubmed: 25873727
J Am Soc Echocardiogr. 2014 Aug;27(8):817-25
pubmed: 24906801
Circulation. 2015 Aug 25;132(8):741-7
pubmed: 26304665
J Am Coll Cardiol. 1993 Nov 15;22(6):1679-83
pubmed: 8227838
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
J Am Coll Cardiol. 2016 Feb 16;67(6):644-655
pubmed: 26868689
Am J Cardiol. 2019 Feb 15;123(4):658-666
pubmed: 30528421